TP53 and neoplasm: To complement these findings, we also performed RNA-seq on the isogenic Ptch + /−:p53 + /+, and Ptch + /−; MSCV-DDp53-GFP tumor cells treated with 200 nM trametinib or vehicle for 5 days (Supplementary Data 3).